1 / 42

Giuseppe Biondi Zoccai University of Turin , Turin , Italy METCARDIO, Turin , Italy gbiondizoccai@gmail.com

THE CURRENT CLOPIDOGREL LOADING DOSE: IRRELEVANT, TOO LOW, OR TOO LATE?. Giuseppe Biondi Zoccai University of Turin , Turin , Italy METCARDIO, Turin , Italy gbiondizoccai@gmail.com. Consensus in Cardiologia: Cardiologi a confronto sull’ aterotrombosi Roma, 20/6/2008 – 9.00-9.20.

susan
Download Presentation

Giuseppe Biondi Zoccai University of Turin , Turin , Italy METCARDIO, Turin , Italy gbiondizoccai@gmail.com

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THE CURRENT CLOPIDOGREL LOADING DOSE: IRRELEVANT, TOO LOW, OR TOO LATE? Giuseppe Biondi Zoccai UniversityofTurin, Turin, Italy METCARDIO, Turin, Italy gbiondizoccai@gmail.com Consensus in Cardiologia: Cardiologi a confronto sull’aterotrombosi Roma, 20/6/2008 – 9.00-9.20

  2. DISCLOSURE • Consultant: Boston Scientific, Cordis, genae, Invatec, Mediolanum Cardio Research • Lecture fees: Bristol-Myers Squibb, Sanofi Aventis • Research grants: AIFA

  3. LEARNING GOALS • What is the currently approved loading dose of clopidogrel and why? • Is it worthwhile to increase the clopidogrel loading dose? • Is it worthwhile to anticipate the loading dose?

  4. LEARNING GOALS • What is the currently approved loading dose of clopidogrel and why? • Is it worthwhile to increase the clopidogrel loading dose? • Is it worthwhile to anticipate the loading dose?

  5. RESHAPING THE EVIDENCE BASE IS CHALLENGING 300 MG LOADING: IMMEDIATELY IN ACS OR >6 HOURS BEFORE PCI

  6. THE CREDO TRIAL Steinhubl et al, JAMA 2002;288:2411-20

  7. 0.14 0.12 0.10 0.08 0.06 0.04 0.02 0.00 THE CURE TRIAL N=12,562 patients with unstable angina or non-ST-elevation myocardial infarction 20% RRR p=0.00009 Placebo + ASA Cumulative hazard rate of CV death, MI or stroke Clopidogrel 300 mg loading and then 75 mg/d + ASA 0 3 6 9 12 Yusuf et al, NEJM 2001;345:494-502

  8. THE CLARITY-TIMI 28 TRIAL Sabatine et al, NEJM 2005;352:1179-89

  9. THE COMMIT TRIAL COMMIT Investigators, Lancet 2005;366:1607-21

  10. LEARNING GOALS • What is the currently approved loading dose of clopidogrel and why? • Is it worthwhile to increase the clopidogrel loading dose? • Is it worthwhile to anticipate the loading dose?

  11. WHEN IS MUCH TOO MUCH?

  12. 600 or 900 MG LOADING? Von Beckerath et al, Circulation 2005;112:2946-50

  13. 600 or 900 MG LOADING? Von Beckerath et al, Circulation 2005;112:2946-50

  14. 600 or 900 MG LOADING? Montalescot et al, J Am Coll Cardiol 2006;48:931-8

  15. 600 MG LOADING IN STABLE PATIENTS – THE ISAR-REACT TRIAL 600 mg of clopidogrel at least 2 hoursbefore PCI Kastrati et al, NEJM 2004;350:232-8

  16. 600 MG LOADING IN UNSTABLE PATIENTS – THE ISAR-REACT 2 TRIAL Kastrati et al, JAMA 2006;295:1531-38

  17. 600 MG LOADING IN AMI – THE BRAVE-3 STUDY p>0.05 % p>0.05 Mehilli et al, ACC 2008

  18. 600 MG RELOADING: THE ARMYDA-RELOAD TRIAL Patients on 75 mg/d of clopidogrel for >10 days 9 6.8 % 0.5 600 mg Clopidogrel reload Placebo DiSciascio et al, ACC 2008

  19. SUMMARY OF EVIDENCE ON CLOPIDOGREL LOADING

  20. SUMMARY OF EVIDENCE ON CLOPIDOGREL LOADING Lotrionte et al, Am J Cardio 2007;100:1199-1206

  21. LEARNING GOALS • What is the currently approved loading dose of clopidogrel and why? • Is it worthwhile to increase the clopidogrel loading dose? • Is it worthwhile to anticipate the loading dose?

  22. WHEN IS EARLY TOO EARLY?

  23. HOW LONG DOES IT TAKE FOR CLOPIDOGREL TO ACT? Hochholzer et al, Circulation 2005;111:2560-64

  24. HOW LONG DOES IT TAKE FOR CLOPIDOGREL TO ACT? 600 mg -> 2 hours Hochholzer et al, Circulation 2005;111:2560-64

  25. THE CREDO TRIAL Steinhubl et al, JAMA 2002;288:2411-20

  26. THE CREDO TRIAL p=0.051 favoring 300 mg clopidogrel loading>6 hours before PCI Steinhubl et al, JAMA 2002;288:2411-20

  27. DOES EARLY 300 MG PRETREATMENT OF STABLE PATIENTS MAKE SENSE?

  28. DOES EARLY 600 MG PRETREATMENT OF STABLE PATIENTS MAKE SENSE?

  29. ANTICIPATING LOADING IN STABLE PATIENTS Widimsky et al, Eur Heart J 2008;29:1495-1503

  30. ANTICIPATING LOADING IN STABLE PATIENTS Widimsky et al, Eur Heart J 2008;29:1495-1503

  31. ANTICIPATING LOADING IN STABLE PATIENTS Widimsky et al, Eur Heart J 2008;29:1495-1503

  32. ANTICIPATING (AND INCREASING) LOADING IN UNSTABLE PATIENTS

  33. ANTICIPATING (AND INCREASING) LOADING IN UNSTABLE PATIENTS Patients with ACS (UA/NSTEMI or STEMI) planned for early invasive strategy, i.e. intend for PCI as early as possible within 72 hrs of randomization RANDOMIZE Clopidogrel High Dose Group Clopidogrel 600mg loading dose Day 1 followed by 150mg from Day 2 to Day 7; then 75mg from Day 8 to 30 Clopidogrel Standard Dose Group Clopidogrel 300mg (+placebo) Day 1 followedby 75mg (+placebo) from Day 2 to Day 7;75mg from Day 8 to 30 RANDOMIZE RANDOMIZE ASA high dose group At least 300mg Day1; 300mg–325mgfrom D2 to D30 ASA low dose group At least 300mg Day1; 75–100mgfrom D2 to D30 ASA high dose group At least 300mg Day1; 300mg–325mgfrom D2 to D30 ASA low dose group At least 300mg Day1; 75–100mgfrom D2 to D30

  34. TAKE HOME MESSAGES

  35. TAKE HOME MESSAGES • Several trials and guidelines support a clopidogrel loading dose of at least 300 mg • A 600 mg loading dose is recommended in patients at high risk of ischemic events and low bleeding risk who are undergoing PCI • These loading doses should be administered immediately at diagnosis in patients with acute coronary syndromes, and between 2 hours before and just before PCI in stable patients

  36. For further slides on these topics please feel free to visit the metcardio.org website:http://www.metcardio.org/slides.html

  37. RESERVE SLIDES

  38. WHAT ABOUT OTHER DRUGS?THE PRINCIPLE-TIMI 44 Wiviott et al, Circulation 2007;116:2923-32

  39. WHAT ABOUT OTHER DRUGS?THE PRINCIPLE-TIMI 44 Wiviott et al, Circulation 2007;116:2923-32

  40. WHAT ABOUT OTHER DRUGS?THE TRITON-TIMI 38 Wiviott et al, Lancet 2008;371:1353-63

  41. WHAT ABOUT OTHER DRUGS?THE TRITON-TIMI 38 Wiviott et al, Lancet 2008;371:1353-63

  42. WHAT ABOUT OTHER DRUGS?THE TRITON-TIMI 38 Wiviott et al, Lancet 2008;371:1353-63

More Related